Federal lawsuits against manufacturers of testosterone replacement therapies alleging the companies withheld risks associated with the products will be consolidated in the U.S. District Court for the Northern District of Illinois. The U.S. Judicial Panel on Multidistrict Litigation (MDL) ordered all federal lawsuits involving testosterone supplements be tried in Chicago. Consolidating the lawsuits is intended to reduce the cost of expert discovery, facilitate the establishment of a uniform pretrial approach to the cases, reduce the potential for inconsistent rulings and conserve resources, the MDL panel wrote. Testosterone replacement therapies, including the widely prescribed AndroGel, Testim and Axiron are designed to boost ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.